Impact Factor
2.77
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.31
137 total citations
h5-index
13
h5 depth signal
Cited share
59.3%
35 of 59
Total citations
137
Citation footprint
Metric signal
1.27
External metric anchor
Self-citation
0.7%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
220
United States
16
Brazil
15
Italy
15
Malaysia
9
Citing Fields of Research
Drug Delivery Systems
197
Nanoparticles
32
Polymer & Macromolecule Science
21
Phytochemicals
19
Dermatology
11
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
596
Articles tracked across the journal lifetime
Indexed publication set
59
35 cited publications
Last 12 months
67
6.1 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
India
220 citing publications
Leading citing field
Drug Delivery Systems
197 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v15, 2021-
v15, 2021-
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Broad Categories
Pharmacology
Drug Delivery Systems
MeSH Descriptors
Drug Compounding
Drug Delivery Systems
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/0126673878488093261002175038
Open DOI
A Comprehensive Review on Nanosphere-Based Drug Delivery System for the Identification and Prevention of Cancerous Cells
Nanospheres are sub-micron-sized solid colloidal particles, typically ranging from 10 to 200 nm in diameter, that have emerged as highly effective carriers for targeted drug delivery and diagnostic applications. Owing to their unique phy...
02
DOI 10.2174/0126673878478166260924052533
Open DOI
Flurbiprofen for Inflammatory Bowel Disease: A Review of Colon-Targeted Formulations
Crohn’s disease and ulcerative colitis are both classified as forms of Inflammatory Bowel Disease (IBD). Strategies that reduce overall systemic exposure while delivering antiinflammatory drug directly to the inflamed colon are necessary...
03
DOI 10.2174/0126673878482717260912102007
Open DOI
Recent Advances in Stimuli Responsive In-Situ Gelling System for the Management of Rheumatoid Arthritis
The chronic autoimmune inflammatory disease known as rheumatoid arthritis (RA) is marked by irreparable joint damage, increasing cartilage loss, immune cell infiltration, and persistent synovial inflammation. Approximately 0.24% of peopl...
04
DOI 10.2174/0126673878528239260911062350
Open DOI
Innovative Approaches for Topical and Transdermal Drug and Cosmeceutical Delivery
In recent years, non-invasive drug delivery methods have emerged as promising alternatives to conventional needle-based injections, with Transdermal Drug Delivery Systems (TDDS) gaining particular attention due to their reduced patient r...
05
DOI 10.2174/0126673878497824260910063724
Open DOI
Targeted Delivery of RNA-based Therapeutics by Lipid Nanoparticles
Lipid Nanoparticles (LNPs) have emerged as adaptable and effective delivery systems for RNA-based therapies, transforming contemporary medicine. This article covers the design, processes, and therapeutic potential of LNPs for RNA deliver...
06
DOI 10.2174/0126673878481318260908095126
Open DOI
Integration of Artificial Intelligence in the Pharmaceutical Sector: From Drug Discovery, Clinical Care, Manufacturing, to Market Delivery—A Review
Artificial Intelligence (AI) is revolutionizing the pharmaceutical industry by enhancing efficiency, precision, and personalization in drug discovery, development, and patient care. This review explores the diverse applications of AI in ...
07
DOI 10.2174/0126673878470511260908043051
Open DOI
Emerging Perspectives Bio-Flexi Film Nanocarriers: A Novel Approach for Brain Drug Delivery through the Trans-Vermilion Route
Therapeutic drugs often cannot effectively cross the Blood-Brain Barrier (BBB) because of its protective properties. The use of conventional treatment methods, such as oral and injectable routes, is limited by poor permeability, enzymati...
08
DOI 10.2174/0126673878496546260903102828
Open DOI
Nano-Carriers in Biofilm-Associated Infections: Clinical Challenges, Regulatory Hurdles, and Translational Perspectives
Biofilms are structured communities of microorganisms encapsulated by an Extracellular Polymeric Substance (EPS) matrix, which plays a crucial role in recurrent and chronic infections caused by implanted medical devices. The natural resi...
09
DOI 10.2174/0126673878465675260827101211
Open DOI
Lectins as Adjuvants and Vaccine Delivery Systems: A Mini-Review
Lectins are carbohydrate-binding proteins that have emerged as promising candidates for vaccine development due to their dual roles as immunomodulatory agents and antigen delivery systems. Through specific interactions with glycans expre...
10
DOI 10.2174/0126673878505831260904095016
Open DOI
Formulation and Physicochemical Characterization of Paliperidone- Loaded Niosomal Vesicles for Improved Transdermal Drug Delivery
Introduction/Objective: Niosomes are nonionic surfactant-based vesicular systems. Paliperidone, which is an atypical antipsychotic used in the management of schizophrenia, exhibits poor aqueous solubility and limited oral bioavailability...
Bibliographical & Catalog Notes
Also issued in print.